ValuEngine downgraded shares of Senomyx (NASDAQ:SNMX) from a sell rating to a strong sell rating in a report published on Friday.
Separately, Zacks Investment Research cut Senomyx from a buy rating to a hold rating in a research report on Wednesday, November 29th.
Senomyx (NASDAQ SNMX) traded up $0.03 during trading hours on Friday, reaching $1.48. The company had a trading volume of 203,300 shares, compared to its average volume of 225,973. Senomyx has a 12-month low of $0.56 and a 12-month high of $1.71.
A hedge fund recently raised its stake in Senomyx stock. Algert Global LLC raised its stake in shares of Senomyx, Inc. (NASDAQ:SNMX) by 14.7% in the third quarter, according to the company in its most recent disclosure with the SEC. The firm owned 359,788 shares of the specialty chemicals company’s stock after acquiring an additional 46,000 shares during the quarter. Algert Global LLC owned approximately 0.75% of Senomyx worth $218,000 as of its most recent filing with the SEC. Institutional investors and hedge funds own 26.86% of the company’s stock.
TRADEMARK VIOLATION WARNING: This piece was published by Chaffey Breeze and is the sole property of of Chaffey Breeze. If you are reading this piece on another publication, it was illegally copied and republished in violation of United States and international trademark & copyright laws. The legal version of this piece can be accessed at https://www.chaffeybreeze.com/2017/12/05/senomyx-snmx-cut-to-strong-sell-at-valuengine.html.
Senomyx, Inc is focused on using taste receptor technologies to discover, develop and commercialize flavor ingredients for the packaged food, beverage and ingredient supply industries. The Company operates through development and commercialization of flavor ingredients segment. It is engaged in the discovery, development and/or commercialization of flavor ingredients through over five programs.
To view ValuEngine’s full report, visit ValuEngine’s official website.
Receive News & Ratings for Senomyx Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Senomyx Inc. and related companies with MarketBeat.com's FREE daily email newsletter.